Finally, KRAS mutations were significantly depleted (p = 0.003; Fisher’s exact test) among the cell lines exhibiting net cell death in response to GSK525762 (Supplemental Table S1), suggesting that activated RAS signaling may be a mechanism by which cancer cells are able to survive BET inhibition. The gene discussed is KRAS; the disease is cancer.